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We report the use of a new label, an expressible enzyme-
coding DNA fragment, for nucleic acid hybridization
assays. The DNA label contains a firefly luciferase coding
sequence downstream from a T7 RNA polymerase pro-
moter. The target DNA (200 bp) is denatured and
hybridized simultaneously with two oligonucleotide probes.
One of the probes is immobilized in microtiter wells, via
the digoxigenin/anti-digoxigenin interaction, and the other
probe is biotinylated. After completion of the hybridiza-
tion, the hybrids are reacted with a streptavidin-lu-
ciferase DNA complex. Subsequently, the solid-phase
bound DNA is expressed by coupled transcription/
translation. The synthesized luciferase catalyzes the
luminescent reaction of luciferin with O2 and ATP. The
luminescence is linearly related to the amount of target
DNA in the range of 5-5000 amol. The CVs obtained
for 20 and 100 amol of target are 6.5% and 10.8%,
respectively (n ) 4).
The specific and strong interaction between two complemen-
tary nucleic acid strands forms the basis for the development of
hybridization assays. Hybridization methodology is emerging as
the most promising area in laboratory medicine and has trans-
formed the way clinical testing is realized. Previous tests have
been based on the monitoring of gene products, i.e., phenotypic
markers, such as oncoproteins, viral antigens, etc. In contrast,
current laboratory tests that are based on hybridization allow the
analysis of disease at the nucleic acid level. Thus, pre- or postnatal
diagnosis of genetic disease can be accomplished by hybridization
of the patient’s DNA with allele-specific oligonucleotide probes
that recognize mutations, deletions, or insertions causing the
disease. Also, the various infectious agents can be measured in
biological fluids by hybridization with specific probes. In forensic
science, hybridization of DNA with minisatellite probes allows the
unique identification of individuals (DNA fingerprinting).1,2
Radioactive probes (usually labeled with 32P), in combination
with autoradiographic detection, dominated in the field of hybrid-
ization assays for more than 2 decades and provide the highest
sensitivities. However, the short half-life of 32P, the health hazards
and problems associated with its use and disposal, and the long
exposure times (many hours to days) required for detection have
placed limitations on the routine use of hybridization assays in
the clinical laboratory. The current trend in this area is toward
novel nonradioactive alternatives.2,3
The labels can be incorporated into the probes either enzy-
matically (e.g., using DNA polymerase or deoxynucleotidyl trans-
ferase and modified deoxynucleoside triphosphates) or by chemi-
cal conjugation (e.g., introduction of NH2 groups into the probe
via cytidine transamination and then conjugation to the reporter
molecule).4 Nonisotopic hybridization assays based on fluores-
cent, chemiluminescent, or enzyme labels have been developed.
Generally, there are two strategies for the analysis of hybrids.
Either the reporter molecule is directly conjugated to the probe,5,6
or a ligand is attached to the probe and the hybrids are measured
in a subsequent step by adding a specific, labeled binding protein.
The ligand may be biotin or a hapten (e.g., digoxigenin). Labeled
(strept)avidin or antihapten antibodies may then be employed for
detection.7,8 Enzymes (such as alkaline phosphatase and horse-
radish peroxidase) are the most widely used nonradioisotopic
labels because they provide amplification through the high
turnover of their substrates to detectable products.2
Recently, we reported9 that a DNA fragment (DNA template)
coding for an enzyme can be used as a novel label for the
development of highly sensitive immunoassays (expression im-
munoassays). In these assays, after completion of the immuno-
reaction, the DNA template (a luciferase-coding DNA) is ex-
pressed by in vitro transcription/translation and the activity of
the synthesized enzyme is measured. Furthermore, it was
estimated that 12-14 luciferase molecules were synthesized from
each DNA template molecule. In the present work, we extend
our investigation in the area of hybridization assays.
EXPERIMENTAL SECTION
Instrumentation. Luminescence measurements were carried
out using a liquid scintillation counter (Model LS-6500, Beckman
Instruments Inc., Fullerton, CA) in the single photon monitoring
mode. Fluorescence measurements were performed with the
Fluoroscan II microplate fluorometer (Labsystems, Needham
Heights, MA) along with the transmit software 4.0. The excitation
and emission wavelengths were set at 355 and 460 nm, respec-
tively. The Amerlite shaker/incubator was from Amersham
Canada Ltd. (Oakville, ON, Canada). The microtiter well washer,
Model EAW II, was from SLT Lab Instruments (Salzburg, Austria).
The G24 environmental incubator shaker was from New Brun-
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swick Scientific (Edison, NJ). An imaging densitometer (Model
GS-670, Bio-Rad Laboratories Ltd., Mississauga, ON, Canada),
along with the molecular analyst version 1.1 software, was used
for quantitation of DNA fragments following electrophoresis.
Reagents. The TNT T7 wheat germ extract, used for the in
vitro coupled transcription/translation reactions, was purchased
from Promega Corp. (Madison, WI). The complete reaction
mixture consisted of wheat germ extract (containing ribosomes,
tRNA, and other translation factors), T7 RNA polymerase, and
amino acids in the appropriate buffer. The mixture was prepared
according to the manufacturer’s instructions. The Wizard PCR
preps DNA purification system and beetle luciferin were also from
Promega. Ultrapure 2′-deoxyribonucleoside 5′-triphosphates
(dNTP), FPLCpure terminal deoxynucleotidyl transferase, coen-
zyme A (CoA), and NAP-5 size exclusion columns were purchased
from Pharmacia Biotech. (Montreal, PQ, Canada). Linear DNA
markers (pUC18 DNA digested with HaeIII), streptavidin, mag-
nesium carbonate pentahydrate, and tricine were from Sigma (St.
Louis, MO). Adenosine triphosphate (ATP), digoxigenin-11-2′-
deoxyuridine 5′-triphosphate (Dig-dUTP), polyclonal antidigoxi-
genin antibody (from sheep), bovine serum albumin, streptavidin-
alkaline phosphatase conjugate, 4-methylumbelliferyl phosphate,
and blocking reagent for hybridization and detection (Catalog No.
1096 176) were obtained from Boehringer (Laval, PQ, Canada).
The Klenow fragment of DNA polymerase I (exonuclease-free)
was purchased from United States Biochemical (Cleveland, OH).
Diethanolamine was from BDH (VWR Scientific, Toronto, ON,
Canada). The chemiluminescent substrate for alkaline phos-
phatase (CSPD) and the chemiluminescence enhancer Sapphire
II were gifts from Tropix (Bedford, MA). Biotin-dATP (biotin
attached at the 6-position of adenine by a 14-atom linker) was
obtained from Life Technologies (Burlington, ON, Canada). “U”
bottom and flat-bottom, transparent polystyrene microtiter wells
(Nunc, Maxisorp) were also from Life Technologies. White, flat
bottom microtiter wells were from Dynatech Laboratories Inc
(Chantilly, VA).
The oligonucleotide probes used in this work were synthesized
by Biosynthesis Inc. (Lewisville, TX). The sequence of the
“capture” probe (a 26-mer) was as follows: 5′-GCTGAA-
GGGCTTTTGAACTCTGCTTA-3′. The “detection” probe (a 22-
mer) had the following sequence: 5′-TCAGACCCTGAGGC
TCAAAGTC-3′.
The “blocking solution” contained 1% (w/v) blocking reagent
in 0.1 mol/L maleate and 0.15 mol/L NaCl, pH 7.5. The “wash
solution” consisted of 50 mmol/L Tris, pH 7.4, 0.15 mol/L NaCl,
and 0.1% (v/v) Tween-20. The “hybridization solution” contained
60 mmol/L sodium citrate and 0.6 mol/L NaCl in blocking solution
(pH 7.5). The Tris-EDTA (TE) buffer consisted of 10 mmol/L
Tris and 1 mmol/L EDTA, pH 7.6.
Preparation of the DNA Target. A 200 bp DNA fragment
was used as a target. It was prepared by amplifying (using nested
polymerase chain reaction) the BCR-ABL mRNA from K562 cells.
The mRNA isolation, reverse transcription, and amplification were
performed as previously described10 but using unlabeled primers.
The amplification product (200 bp) was purified from the excess
of primers and dNTPs with the Wizard PCR preps DNA purifica-
tion system and stored at 4 °C. The concentration of the stock
solution of target DNA was determined by imaging densitometry
as follows. The DNA target was electrophoresed in a 2% agarose
gel and stained with ethidium bromide (0.6 mg/L in the running
buffer). A lane containing linear DNA markers with known
concentrations was also included for construction of a calibration
curve. The gel was photographed, under UV exitation, by using
a Polaroid 665 film, and the negative was scanned by the
densitometer. Solutions of target DNA at various concentrations
were prepared by diluting the stock with a diluent containing 1%
(w/w) blocking reagent in distilled autoclaved water.
Labeling of the Oligonucleotide Probes. The capture probe
was labeled at the 3′ end with Dig-dUTP by using terminal
deoxynucleotidyl transferase. The labeling reaction was carried
out in a final volume of 20 µL consisting of 0.2 mol/L potassium
cacodylate, 25 mmol/L Tris-HCl (pH 6.6), 0.25 g/L bovine serum
albumin, 5 mmol/L CoCl2, 42 µmol/L of each dNTP, 16.7 µmol/L
Dig-dUTP, 100 pmol of probe, and 24 units of terminal transferase.
The reaction mixture was incubated at 37 °C for 45 min, after
which the labeled probe was purified two times by size exclusion
chromatography on Sephadex G-25 disposable columns (Nap-5)
equilibrated with 10 mmol/L sodium phosphate buffer, pH 6.8.
The detection probe was labeled at the 3′ end with biotin-dATP.
The reaction was carried out exactly as above but 0.5 mmol/L
dATP and 0.05 mmol/L biotin-dATP were included in the reaction
mixture instead of dNTP and Dig-dUTP, respectively. After
labeling and purification, the probes were stored at -20 °C.
Preparation of Streptavidin-Luciferase Coding DNA Com-
plex. An expressible DNA fragment containing the T7 RNA
polymerase promoter and a luciferase-coding sequence was
prepared as previously described9 with some modifications.
Briefly, a suitable plasmid was digested with Alw 44 I, which
produced three fragments with recessed 3′ ends. The ends were
filled-in with dGTP, dCTP, dTTP, and biotin-dATP by using the
Klenow DNA polymerase. As a result, all the fragments were
biotinylated at both termini. The DNA was purified from the
excess of biotin-dATP by precipitation with 2 volumes of cold (4
°C) ethanol and 0.1 volume of 3 mol/L sodium acetate, pH 5.2. A
small segment (0.49 kbp) was then removed from one end of the
luciferase-coding DNA fragment just upstream of the T7 promoter,
thus leaving a 2.1 kbp fragment labeled with biotin only at one
terminus. After electrophoretic separation, the band of interest
was excised, the DNA was purified, and its concentration was
determined by densitometry. The biotinylated DNA was then
complexed with a 30-fold molar excess of streptavidin in 1 mol/L
NaCl. The complex was purified by HPLC (using a size exclusion
column), concentrated, and stored at 4 °C in a solution containing
1 mol/L NaCl and 1 mmol/L EDTA, pH 8.0.
Hybridization Assays Using a Luciferase-Coding DNA
Fragment as Label. “U” bottom polystyrene microtiter wells
were coated overnight at 4 °C, by physical adsorption, with 25 µL
of 5 mg/L anti-digoxigenin antibody solution in 0.1 mol/L sodium
carbonate, pH 9.6. The wells were washed twice with wash
solution, and the remaining binding sites were blocked with 100
µL blocking solution for 60 min at room temperature. The wells
were washed twice as above and 25 µL of 2.4 nmol/L Dig-labeled
capture probe, diluted in blocking solution, was pipeted into each
well and incubated for 60 min. The unbound probe was then
removed by washing the wells three times with wash solution.
Subsequently, 10 µL of 10 nmol/L biotinylated detection probe,
diluted in hybridization solution and preheated at 42 °C, was added
into each well. The target DNA was denatured by heating at 95
°C for 7 min and kept on ice. A 15 µL aliquot of the denatured(10) Bortolin, S.; Christopoulos, T. K. Anal. Chem. 1994, 66, 4302-7.
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DNA target was then pipeted into each well. The hybridization
of the target with the immobilized capture probe and the detection
probe was allowed to proceed for 60 min at 42 °C with shaking.
At the end of this incubation period, the wells were washed three
times, to remove the excess of detection probe. Then, 25 µL of
1.7 mg/L (with respect to DNA) streptavidin-luciferase DNA
complex, diluted in hybridization solution, was added into each
well and incubated for 20 min. The wells were washed four times
with wash solution and one time with cold (4 °C) TE buffer.
Afterward, 25 µL of the transcription/translation mixture was
added into each well and incubated at 30 °C for 90 min (in the
G24 incubator) to allow for the expression of the solid-phase bound
luciferase-coding DNA. The synthesized luciferase was then
measured by pipeting 10 µL of the reaction mixture into 50 µL of
substrate solution11 (20 mmol/L tricine, 1.1 mmol/L magnesium
carbonate pentahydrate, 2.7 mmol/L MgSO4, 0.1 mmol/L EDTA,
33 mmol/L dithiothreitol, 270 µmol/L CoA, 530 µmol/L ATP, and
470 µmol/L luciferin, pH 7.8) in a microcentrifuge tube. The tube
was placed in a glass scintillation vial, and the luminescence was
measured for 1 min using a liquid scintillation counter in the single
photon monitoring mode.
Fluorescence Hybridization Assays. The coating of the
wells, the immobilization of the capture probe, and the hybridiza-
tion reaction were carried out as described above (see Hybridiza-
tion Assays Using a Luciferase-Coding DNA Fragment as Label)
except that flat-bottom wells were used and the reagent volumes
were 50 µL instead of 25 µL. After completion of the hybridization
reaction, the wells were washed three times and 50 µL of 100
units/L streptavidin-alkaline phosphatase conjugate, diluted in
hybridization solution, was pipeted into each well and incubated
for 15 min. The wells were washed three times with wash
solution, and 50 µL of substrate solution (0.1 mmol/L 4-methyl-
umbelliferyl phosphate, 0.1 mol/L Tris, 0.1 mol/L NaCl, and 1
mmol/L MgCl2, pH 9.1) was added into each well. After a 60
min incubation period, the solution was transferred into white
wells and the fluorescence was measured with the microplate
fluorometer.
Chemiluminescence Hybridization Assays. The reactions
involved in the chemiluminescence hybridization assays, up to
the addition of streptavidin-alkaline phosphatase conjugate, were
as described above (see Fluorescence Hybridization Assays).
Next, 50 µL of substrate solution (0.4 mmol/L CSPD, 1 g/L
sapphire II, 0.1 mol/L diethanolamine, and 1 mmol/L MgCl2, pH
9.5) was added into each well and incubated for 30 min. The wells
were then placed in glass scintillation vials, and the luminescence
was measured for 0.15 min with the liquid scintillation counter in
the single photon monitoring mode.
RESULTS AND DISCUSSION
The principle of the hybridization assay is illustrated in Figure
1. The capture probe was tailed with Dig-dUTP, and after
purification, it was bound to polystyrene wells coated with anti-
digoxigenin antibody. Denatured DNA target was hybridized
simultaneously with the immobilized capture probe and the
detection probe which was tailed with biotin-dATP. The hybrids
were reacted with a preformed streptavidin-DNA complex. The
complex was prepared by mixing biotinylated luciferase-coding
DNA with a large excess of streptavidin. This ensures that the
complex has at least one site available for binding to the
biotinylated detection probe. The assay was completed by
expressing the solid-phase bound DNA label and measuring the
activity of synthesized luciferase. Luciferase catalyzes the lumi-
nescent reaction of luciferin, O2, and ATP to produce oxyluciferin,
AMP, pyrophosphate, and CO2.12,13 Because the T7 promoter
sequence is present only in the DNA label, the transcription/
translation process uses the luciferase-coding DNA exclusively,
and not the probe-target hybrids.
The time required for completion of the hybridization reaction
was studied in the range of 15-120 min, and the results are
presented in Figure 2. The signals reported are corrected for
the background. The background is the luminescence obtained
in the absence of target DNA and is a measure of nonspecific
binding of the detection probe and the streptavidin-DNA complex
to the solid phase. A rapid increase of the luminescence in the
first 60 min of incubation is observed and then a plateau is reached
where the signal increases by only 15% in the second hour of
incubation. With the increase in hybridization time, the back-
ground did not change. The average value for the background
was 29 477 counts/min. Thus, the hybridization time was kept
constant at 1 h for all subsequent experiments.
The effect of the streptavidin-DNA concentration was studied
by preparing various dilutions of the complex in hybridization
(11) Titus, D. E. Promega Protocols and Applications Guide, 2nd ed.; Promega
Corp.: Madison, WI, 1991.
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Figure 1. Principle of the hybridization assay using a luciferase-coding DNA fragment as a label. The target DNA is 200 bp and the expressible
DNA label is 2.1 kbp. The relative positions of the capture and detection probes are shown: D ) digoxigenin; B ) biotin; SA ) streptavidin; T7
) T7 RNA polymerase promoter. The arrow shows the direction of transcription and translation.
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buffer and using them in the assay of 500 amol of target DNA
(Figure 3). As the complex concentration is increased, a continu-
ous increase of the luminescence signal is observed. A plateau
is reached at 1.7 mg/L (30 fmol/well). At a higher concentration
there is a significant increase of the nonspecific binding of the
complex and the signal-to-background ratio drops.
In order to assess the sensitivity and linear range of the
optimized assay, target DNA was serially diluted in a solution
containing 1% (w/v) blocking reagent in water and aliquots were
analyzed. In Figure 4A, the luminescence is plotted vs the amount
of target DNA. As low as 5 amol of target can be detected with
a signal-to-background ratio of 2. Also, the luminescence is
linearly related to the amount of target DNA up to about 5000
amol. It is therefore proved that although the transcription/
translation process consists of a series of complex (and not fully
understood) reactions, which require the concerted action of
numerous factors (such as RNA polymerase, translation initiation,
elongation and termination factors, ribosomal subunits, and
aminoacyl-tRNA synthetases), the final outcome is a simple linear
relationship between the target DNA (analyte) and the activity of
the in vitro synthesized luciferase. In order to enhance the
practicality of the assay, we performed the transcription/transla-
tion reaction in one step (addition of a single reagent).
The reproducibility of the proposed system was studied by
analyzing 20 and 100 amol of target DNA in quadruplicate, in the
same run. The CVs obtained were 6.5 and 10.8%, respectively
(n ) 4).
The proposed methodology was compared directly with a
fluorescence and a chemiluminescence hybridization assay. In
these assays a streptavidin-alkaline phosphatase conjugate was
used, instead of the streptavidin-DNA complex, for detection of
the hybrids. The activity of solid-phase bound alkaline phos-
phatase was then measured by using a fluorescent (4-methylum-
belliferyl phosphate) or a chemiluminescent substrate (CSPD).
The results are presented in Figure 4B. The fluorescence assay
can detect 200 amol of target DNA with a signal-to-background
ratio of 2.4. The chemiluminescence assay gave a signal-to-
background ratio of 3.2 for 100 amol of target DNA. The curvature
observed at high levels of target DNA is due to saturation of the
liquid scintillation counter from the light produced.
The total time required for completion of the proposed assay
is 230 min. The fluorescence and chemiluminescence hybridiza-
tion assays are completed in 195 and 165 min, respectively.
Nevertheless, the lower sample throughput of the expression-
based assay is compensated by its higher sensitivity.
Generally, any DNA fragment that contains an enzyme-coding
sequence positioned downstream from a potent RNA polymerase
promoter can be used as a label. The luciferase-coding DNA was
chosen in this work because luciferase is a single polypeptide
chain (550 amino acids), it requires no posttranslational modifica-
tion, and its activity can be readily measured in the transcription/
translation mixture without prior purification. Because of these
attractive properties, the luciferase cDNA has been used exten-
sively as a reporter gene to monitor gene expression in various
tissues.14 However, to our knowledge, luciferase has not been
(14) Alam, J.; Cook, J. L. Anal. Biochem. 1990, 188, 245-54.
Figure 2. Time dependence of the hybridization reaction. The
assays were carried out as described in the Experimental Section
with 500 amol of target DNA. The concentration of streptavidin-
luciferase DNA complex was 0.86 mg/L.
Figure 3. Optimization of the concentration of streptavidin-
luciferase DNA complex. The solid and dashed lines represent the
luminescence and the signal/background ratio, respectively. The
hybridization assays were carried out as described in the Experimental
Section with 500 amol of target DNA. The concentrations refer to the
DNA label.
Figure 4. (A) Quantitation of DNA target by hybridization assay
using the luciferase-coding DNA fragment as a label. The assays were
carried out as described in the Experimental Section, and the
luminescence was plotted against the amount of target DNA present
in the well. (B) Quantitation of the target DNA by (1) a chemilumi-
nescence and (2) a fluorescence hybridization assay. The assays
were performed as described in the Experimental Section, and the
luminescence or the fluorescence were plotted vs the amount of target
DNA present in the well.
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used as a reporter molecule in hybridization assays. This is
probably due to the significant loss of enzymatic activity upon
conjugation.15 Geiger et al. have used the firefly luciferase-
catalyzed reaction in hybridization assays as an indicator reaction.2
The probes were labeled with alkaline phosphatase, and luciferin
phosphate was used as a substrate. The luciferin released was
measured with high sensitivity using excess of luciferase. A
distinct advantage of the system proposed here is that a luciferase-
coding DNA fragment is used as a label instead of the enzyme
itself, thus avoiding the problem of inactivation. The synthesized
luciferase remains free in the solution.
Because enzymes are the most widely used nonradioactive
labels in nucleic acid hybridization assays, recent efforts have
focused on the design of substrates that allow monitoring of
enzymatic activity with greater sensitivity. The highest sensitivi-
ties are achieved with substrates that are either converted to
chemiluminescent molecules (e.g., CSPD for alkaline phos-
phatase) or give products that form fluorescent chelates with
lanthanide ions allowing determination by time-resolved fluorom-
etry (e.g., fluorosalicyl phosphate for alkaline phosphatase).2,3 The
assay described here is complementary to these efforts because,
in principle, any enzyme-coding DNA may be used as a label in
combination with the best substrate for that particular enzyme.
An alternative approach for further enhancing the sensitivity
of hybridization assays is to attach multiple enzyme molecules to
the probe-target hybrids, thus introducing an additional ampli-
fication step. This has been accomplished by using sequential
hybridization with three types of probes.16 The primary probe
contains two parts, a region complementary to the target and a
segment that allows binding of a polymerized secondary probe
(amplification multimer). Then, each secondary probe reacts with
an enzyme-labeled probe. Thus, branches of DNA are formed
which carry several enzyme molecules. The present work
represents a novel approach for introducing multiple enzyme
molecules in the system, because from a single expressible DNA
fragment several enzyme molecules (12-14 luciferase molecules)
can be synthesized by in vitro transcription and translation.9
From our perspective, the following directions of ongoing
research hold the potential for dramatically improving the sensitiv-
ity and versatility of the proposed system: (a) Efforts aiming at
increasing the yield of the transcription/translation reaction. This
can be accomplished by improving the DNA label and/or by
optimizing the transcription/translation mixture. The design of
labels containing appropriate enhancer and termination sequences
will ensure the highest yield.17,18 Also, the synthesis of capped
RNA has been reported to increase the translation efficiency.19
(b) Another area of investigation involves the preparation of
expressible DNA fragments that code for other enzymes, the
activity of which can be monitored with high sensitivity (e.g.,
alkaline phosphatase). (c) Finally, the sensitivity could be
improved by conjugating, directly, the DNA label with the specific
probe, thus eliminating the need for biotinylated reagents and
streptavidin.
In conclusion, we have designed, for the first time, a hybridiza-
tion assay that utilizes as a label an expressible DNA fragment
coding for an enzyme. The assay is automatable because it is
performed in microtiter wells and avoids blotting procedures and
membrane hybridization. The high sensitivity achieved is a result
of the combined amplification due to transcription/translation and
the substrate turnover. In our opinion, the proposed system may
have a significant impact on hybridization technology and clinical
diagnostics.
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